Which has the lower trailing P/E, AUPH or VCEL?

AUPH has the lower trailing P/E: AUPH trades at 6.85 and VCEL at 85.61. P/E is one valuation measure and does not by itself establish which business is cheaper.

Which has grown faster, AUPH or VCEL?

Over the past five years, AUPH grew revenue faster — AUPH at a 40.17% CAGR versus VCEL at 15.11%.

Is AUPH or VCEL more profitable?

AUPH runs the higher net margin — AUPH at 100.84% versus VCEL at 7.91%.

How have AUPH and VCEL total returns compared?

Over the past 10 years, AUPH delivered 14.53% and VCEL delivered 30.18% annualized total return. Past performance doesn't predict future results.

Aurinia Pharmaceuticals Inc. (AUPH) vs Vericel Corporation (VCEL)

A side-by-side comparison of Aurinia Pharmaceuticals Inc. and Vericel Corporation across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.

AUPH

Aurinia Pharmaceuticals Inc.

$2.02B

$15.69HealthcareDelayed quote: Oct 6, 2026, 4:00 PM EDT

VCEL

Vericel Corporation

$2.05B

$40.05HealthcareDelayed quote: Oct 6, 2026, 4:00 PM EDT

Total return — AUPH vs VCEL

growth of $100 · dividends reinvested · last 10y

AUPH +288.1% (+14.5%/yr)VCEL +1356.4% (+30.7%/yr)VCEL compounded faster over this window

AUPH VCEL

AUPH vs VCEL: by the numbers

•VCEL is the larger company ($2.05B vs $2.02B market cap).
•AUPH trades at the lower trailing earnings multiple (6.85 vs 85.61 P/E), one valuation lens rather than an overall verdict.
•AUPH converts more revenue to profit (100.84% vs 7.91% net margin).
•AUPH grew revenue faster over the past five years (40.17% vs 15.11% CAGR).

Metrics side by side

Valuation

Metric	AUPH	VCEL
P/E ratio	6.85	85.61
Forward P/E	16.62	74.94
PEG ratio	N/A	2.17
P/S ratio	6.48	6.70
P/B ratio	3.28	5.54
EV / EBITDA	11.16	65.14
FCF yield	8.60%	2.42%

Profitability

Metric	AUPH	VCEL
Gross margin	90.36%	74.56%
Operating margin	37.06%	5.95%
Net margin	100.84%	7.91%
ROE	51.09%	6.55%
ROIC	21.77%	3.79%

Growth (annualized)

Metric	AUPH	VCEL
Revenue CAGR (5Y)	40.17%	15.11%
EPS CAGR (5Y)	N/A	39.14%
FCF CAGR (5Y)	N/A	14.83%
Total return CAGR (5Y)	-5.88%	-4.18%

Frequently asked

Which has the lower trailing P/E, AUPH or VCEL?: AUPH has the lower trailing P/E: AUPH trades at 6.85 and VCEL at 85.61. P/E is one valuation measure and does not by itself establish which business is cheaper.
Which has grown faster, AUPH or VCEL?: Over the past five years, AUPH grew revenue faster — AUPH at a 40.17% CAGR versus VCEL at 15.11%.
Is AUPH or VCEL more profitable?: AUPH runs the higher net margin — AUPH at 100.84% versus VCEL at 7.91%.
How have AUPH and VCEL total returns compared?: Over the past 10 years, AUPH delivered 14.53% and VCEL delivered 30.18% annualized total return. Past performance doesn't predict future results.

Go deeper

Full AUPH analysis Full VCEL analysis Interactive comparison tool

Dig into the metrics

Aurinia Pharmaceuticals P/E ratio Vericel P/E ratio Aurinia Pharmaceuticals ROE Vericel ROE Aurinia Pharmaceuticals operating margin Vericel operating margin Aurinia Pharmaceuticals revenue growth Vericel revenue growth Aurinia Pharmaceuticals free cash flow Vericel free cash flow

Aurinia Pharmaceuticals & Vericel appear in these rankings

Fastest Revenue Growth Stocks Highest ROE Stocks Highest ROIC Stocks Highest Operating Margin Stocks

Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.